Calanus rebrands as Zooca

By Will Chu

- Last updated on GMT


Related tags: Calanus, Zooca, Epa, Dha, omega-3

Norwegian biomarine company Calanus is to rebrand under the new name ‘Zooca’ in a move designed to strengthen product identity as part of the firm’s expansion plans into other regions.

In last week’s announcement, the makers of Calanus finmarchicus​-derived omega-3 oil, said the trademark rebrand ‘will encompass both company and product range,’ as well as the food’s importance in the long-term.’

“We cannot wait to make the fantastic properties of the zooplankton Calanus finmarchicus known to the people of the world and we have therefore chosen a name that represents the words “zooplankton” and “Calanus”- Zooca,”​ says CEO Siv-Katrin Ramskjell.

“With Zooca, we create a brand with strong identity. We want to communicate optimism and hope, and we are eager show why these products are important to people and animals around the globe.

“Utilisation of marine resources at the base of the food chain is the way of the future to supply enough nutrients to the world.”

Broodstock Capital investment

The rebrand coincides with Broodstock Capital’s €10m investment in Zooca last month, where the  investment firm became the major shareholder in the company.

Under terms of the agreement, Calanus receives €9.7m (NOK100m) in new equity through a private placement. Meanwhile, Broodstock Capital intends to purchase shares from existing shareholders.

“Calanus is a pioneer when it comes to innovation and sustainable use of biomarine resources,and has the potential to see a new standard for the Norwegian biomarine industry, with processing inworld class,” ​says Pål Kristian Moe, Partner at Broodstock Capital.

“They in turn will be able to lead to increased value creation and employment as well as ripple effects locally and for the industry.

“Broodstock wants to push Calanus all the way to commercial production and has therefore chosen to enter with both capital and expertise,” ​he adds.

Bioactive omega-3 form

The Tromsø -based firm’s main product is its bioactive form of omega-3 that is said to counteract insulin resistance and other obesity-induced metabolic disorders. It also exhibits a potent anti-inflammatory effect.

Extracted from the copepods of the same name Calanus finmarchicus​, the oil contains the omega-3s Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) predominantly in the wax ester form (the oil is slightly viscous). The oil also contains astaxanthin, which gives it its ruby colour.

A recent review​ identified one possible mechanism of action of the oil, appearing to act as a potent stimulators of the GPR120 receptor, which is associated with reduced inflammation.

Related news

Related products

show more

Children’s Bones Need Vitamins K2 & D3

Children’s Bones Need Vitamins K2 & D3

NattoPharma – Gnosis by Lesaffre | 27-Sep-2021 | Data Sheet

Childhood is a crucial period for developing healthy bone mass. However, research shows children have 8-10x higher levels of inactive osteocalcin, which...



BIONAP Srl | 07-Sep-2021 | Product Brochure

COGNIGRAPE™ is a standardized solid extract obtained from a Sicilian grape variety. Thanks to the high content of ANTHOCYANINS and PROANTHOCYANIDINS, COGNIGRAPE™...

Turmacin®: Clean Label & Clinically Tested Turmeric

Turmacin®: Clean Label & Clinically Tested Turmeric

Natural Remedies Private Limited | 01-Sep-2021 | Product Presentation

Turmacin® is a clean label project-certified, clinically tested, and clinically safe turmeric extract. Turmacin® is rich in Turmerosaccharides® and doesn't...

Quatrefolic®: The Active folate vs Folic Acid

Quatrefolic®: The Active folate vs Folic Acid

Gnosis by Lesaffre USA | 31-Aug-2021 | Infographic

Folate deficiency concerns everyone at every step of their life. The supplementation of vitamin B9 is often be misunderstood, especially regarding the...

Related suppliers

Follow us


View more